US 11340237
Metabolite biomarkers for diseases associated with the contact activation system
granted A61PA61P43/00A61P7/10
Quick answer
US patent 11340237 (Metabolite biomarkers for diseases associated with the contact activation system) held by Takeda Pharmaceutical Company Limited expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P43/00, A61P7/10